Zusammenfassung
Die Pathogenese erworbener Thrombozytopathien ist bisher nur unzureichend aufgeklärt. Klinische Erfahrung zeigt, daß bei Patienten mit lokaler oder disseminierter intravasaler Gerinnung, wie sie z. B. im Rahmen einer Sepsis beobachtet wird, eine Störung der primären Blutstillung auftreten kann, die über das Maß der Thrombozytopenie hinausgeht. In den vorliegenden Untersuchungen wurden deswegen Thrombozyten in vitro mit Thrombin behandelt und funktionelle sowie biochemische Eigenschaften derartiger Plättchen bestimmt.
Mit Unterstützung der Deutschen Forschungsgemeinschaft (Re 555/1-1)
und (Scha 358/1-1)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Massini P, Käser-Glanzmann R, Löscher EF (1978) Movement of calcium ions and their role in the activation of platelets. Thromb Haemostas 40: 212
Mustard JF, Perry DW, Ardlie NG, Packham MA (1972) Preparation of suspensions of washed platelets from humans. Br J Haematol 22: 193
Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF (1976) In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemostas 35: 151
Bunting S, O’Grady J, Fabiani JN, Terrier E, Moncada S, Vane JR, Dubost C (1981) Cardiopulmonary bypass in man: effects of prostacyclin. In: Lewis PJ, O’Grady J (eds) Clinical pharmacology of prostacyclin. Raven Press, New York, p 201
Davies GC, Mowschenson PM, Salzman EW (1978) Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis. Surg Forum 29: 471–472
Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective a-granule release. Blood 56: 824–834 —
Heinrich D, Schleussner E, Walter P, Wagner WL, Seilmann R, Ditter H, Matthias FR, Hehrlein FW (1981) Einfluß von Prostacyclin auf das Hämostasepotential unter den Bedingungen der extrakorporalen Zirkulation bei aortokoronaren Venenbypassoperationen. In: Blümel G, Haas S (Hrsg) Mikrozirkulation and Prostaglandinstoffwechsel. Schattauer, New York Stuttgart, S 241 —
Hennessy VL, Hicks RE, Niewiarowski S, Edmunds LH, Colman RW (1977) Function of human platelets during extracorporeal circulation. Am J Physiol 232: H622 — H628
Longmore DB, Gueirrara D, Bennett G, Smith M, Bunting S, Reed P, Moncada S, Read NN, Vane JR (1979) Prostacyclin: a solution to some problems of extracorporeal circulation (experiments in greyhounds). Lancet 2: 1002–1005
McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M (1975) The hemostatic mechanism after openheart surgery. II Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 70: 298–308
Moncada S, Gryglewsky R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665 —9. Moncada S, Vane JR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30: 293–331
Peskar BA, Anhut H, Kröner EE, Peskar BM (1979) Development, specificity and some applications of radioimmunoassays for prostaglandins and related compounds. In: Tillement JP (ed) Advances in pharmacology and therapeutics, vol 7. Pergamon Press, Oxford New York, p 275
Woods HF, Ash G, Weston MJ, Bunting S, Moncada S, Vane JR (1978) Prostacyclin can replace heparin in hemodialysis in dogs. Lancet 2: 1075–1077
Roskamm H (1981) Herzinfarkt im jugendlichen Alter (unter 40 Jahren) Risikofaktoren, Koronarmorphologie, Prognose und Progression der Koronargefäßsklerose. Cardiology 68: 23–30 —
Gohlke H, Stürzenhofecker P, Thilo A, Droste C, Görnandt L, Roskamm H (1981) Coronary angiographic findings and risk factors in postinfarction patients under the age of 40. In: Roskamm H (ed) Myocardial infarction at young age. Springer, Berlin Heidelberg New York, p 61
Burkart F (1981) Die koronare Herzkrankheit beim jungen Patienten unter 35 Jahren in der Schweiz. Schweiz Med Wochenschr 110: 1631–1643
Rutsch W, Schmutzler H (1981) Intracoronary fibrinolysis in acute myocardial infarction in young patients. In: Roskamm H (ed) Myocardial infarction at young age. Springer, Berlin Heidelberg New York, p 156
Ritter B, Schöll V, Gohlke H, Betz P, Budde U, Behnke B, Roskamm H (1982) Spielt der Plättchenfaktor 4 bei der Pathogenese des Herzinfarktes während körperlicher Belastung eine Rolle? (Abstract) Z Kardiol 48: 218
Pepper DS, Ludlam CA (1977) Beta-Thromboglobulin — A new approach to the diagnosis of thrombosis. In: Mills DCB, Pareti FI (eds) Platelets and thrombosis. Proceedings of the Serono Symposium, vol 10. London New York San Francisco, p 145
Delaye J, Beaune J, Delahaye JP (1981) Myocardial infarction at young age during high physical exercise. In: Roskamm H (ed) Myocardial infarction at young age. Springer, Berlin Heidelberg New York, p 115
Pic A, Broustet JP, Saliou B, Gosse P, Guern P (1981) Coexistence of vigorous exercise and heavy smoking on triggering acute myocardial infarction in men under 35 years — Fact or fiction? In: Roskamm H (ed) Myocardial infarction at young age. Springer, Berlin Heidelberg New York, p 108
Gohlke H, Gohlke-Bärwolf C, Stürzenhofecker P, Görnandt L, Roskamm H (1981) Der transmurale Herzinfarkt unter 40 Jahren — Korrelation von angiographischen Befunden mit Riskofaktoren und Anamnese bei 619 Patienten (Abstract) Z Kardiol 69: 724
Dawes J, Smith RL, Pepper DS (1978) The release, distribution and clearance of human ß-thromboglobulin and platelet factor 4. Thromb Res 12: 851–861
Schmitz-Huebner U, Balleisen L, Asbeck F, van de Loo J (1981) In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions. Thromb Haemostas 46: 612–616
Busch C, Dawes J, Pepper DS, Wasteson A (1980) Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 19: 129–137
Yin ET, Wessler S, Butler J (1973) Plasma heparin: A unique, practical, submicrogram sensitive assay. J Lab Clin Med 81: 298–310
Pumphrey CW, Pepper DS, Dawes J (1979) Heparin-PF 4 pulsing as a measure of platelet endothelial cell reaction in vivo. Thromb Haemostas 42: 43 (Abstract)
Asbeck F, Meyer-Boernecke D, van de Loo J (1977) Inhibition of fibrinolytic system in Behçet’s disease? Haemostasis 6: 303–309
Brown C, Bradshaw W, Natelson C (1976) Defective platelet function following the administration of penicillin compounds. Blood 47: 949–956
Johnson G, Rao G, White J (1978) Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Am J Pathol 91: 85–106
Andrassy K, Scher M, Ritz E, Walter E (1976) Penicillin-induced coagulation disorder. Lancet 2: 1039–1041
Andrassy K, Zimmermann R, Höffler D, Ritz E (1977) Plättchenfunktionsstörung — eine Carbenicillin-Nebenwirkung bei normaler Nierenfunktion. Klin Wochenschr 55: 1021–1023
Cazenave J, Guccione M, Packham M, Mustard J (1977) Effects of cephalotin and penicillin G on platelet function in vitro. Br J Haematol 35: 135–152
Shattil S, Bennett J, Donough M, Turnbull J (1980) Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest 65: 329–337
Salzman W, Levine L (1971) Cyclic 3’5’-adenosine monophosphate in human platelets. J Clin Invest 50: 131–141
Bruno J, Taylor L, Droller M (1974) Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation. Nature 231: 721–723
Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with vinblastineloaded platelets. N Engl J Med 298: 1101
Bowring CS, Glass HI, Lewis SM (1976) Rate of clearance by the spleen of heat-damaged erythrocytes. J Clin Pathol 29: 852–854
Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P (1974) Immunsuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 56: 4
Fineman SM, Mudawwar FB, Geha RS (1979) Characteristics and mechanisms of action of the concanavalin A-activated suppressor cell in man. Cell Immunol 45: 120–132
Imbach P, Barandun S, d’Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228–1230
McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135–1147
Mueller-Eckhardt C, Mahn I, Schulz G, Mueller-Eckhardt G (1978) Detection of platelet autoantibodies by a radioactive anti-immunoglobulin test. Vox Sang 35: 357
Schmidt RE, Mueller-Eckhardt C, Kayser W, Budde U, Schneider M, Stroehmann I (1979) Die Wirkung von Vinblastin-beladenen Thrombozyten im Fall einer idiopathischen thrombozytopenischen Purpura Immun Infekt 7: 129–133
Schmidt RE, Budde U, Schäfer G, Stroehmann I (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 2: 475–476
Aberg M, Nilsson IM, Hedner U (1973) Antithrombin III after operation. Lancet 2: 1337 —
Gofferje H, Fekl W (1979) Diagnostik der Mangelernährung. Infusionstherapie 6: 95–99 —
Hedner U, Nilsson IM (1973) Antithrombin III in a clinical material. Thromb Res 3: 631–641 —
Jorgensen KA, Stoffersen E, Sorensen PJ, Ingeberg S, Hüttel M, Ahlbom G (1980) Alteration in plasma antithrombin III following total hip replacement and elective cholecystectomy. Scand J Haematol 24: 101–104
Lechner K, Thaler E, Niessner H, Nowotny Ch, Partsch H (1980) Antithrombin III-Mangel und Thromboseneigung. Wien Klin Wochenschr 89: 215–222
Reinicke R, Matthias FR, Lasch HG (1977) Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy. Thromb Res 11: 365–375
Samama H (1980) Low-dose heparin in gynecological surgery: Effect on blood coagulation tests. Scand J Haematol [Supp1 36] 25: 101–106
Schöndorf TH, Lasch HG (1980) Antithrombin III and factor Xa determination in patients with lowdose heparin and hip surgery. In: Lijnen HR, Collen D, Verstraete M (eds) Synthetic substrates in clinical blood coagulation assays. Dev Haematol 1: 51–57
Schöndorf TH (1981) Wertigkeit und Grenzen der Low-dose-Heparinprophylaxe zur Verhütung postoperativer thromboembolischer Komplikationen. Hämostaseologie 1: 143–153
Fritsche HM, Stemberger A, v Sommoggy S, Fischer M, Blümel G (1981) Zur Pathogenese des Gerinnungsdefektes im akuten Leberversagen. Med Welt 32: 389–392
Heene DL (1979) Hämostasestörungen bei Lebererkrankungen. In: Kühn HA, Wernze H (Hrsg) Klinische Hepatologie. Thieme, Stuttgart, S 3105–3119
Greenlee HB, Malcolm MS, Reinhardt GF (1981) Intractable ascites treated with peritoneovenous shunts. Arch Surg 116: 518–524
Stein SF, Fulenwider JT, Ansley JD, Evatt BL (1981) Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med 141: 1149–1151
Tawes RL, Sydorak GR, Kennedy PA, Brown WH, Scribner RG, Beare JP, Harris EJ (1981) Am J Surg 142: 52–55
Liehr H (1982) Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Ergeb Inn Med Kinderheilkd 48: 117–193
Schölmerich J, Diener W, Maier KP, Eckart F, Gerok W (1981) Short term reinfusion a successfull treatment of refractory ascites. Crit Care Med 9: 278
Gordon S, Unkeless J, Cohn ZA (1974) Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis. J Exp Med 140: 995
Fletcher AP, Biederman O, Moore D, Alkajaersig N, Sherry S (1964) Abnormal plasminogen-plasmin system activity in patients with hepatic cirrhosis: Its cause and consequences. J Clin Invest 43: 681–695
Maier RV, Ulevitch RJ (1981) The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. J Immunol 127: 1596–1800
Vassalli JD, Hammilton J, Reich E (1976) Macrophage plasminogen activator: Modulation of enzyme production by antiinflammatory steroids. Cell 8: 271–281
Hamilton JA (1981) Regulation of prostaglandin and plasminogen activator production by mouse peritoneal macrophages. J Reticuloendothel Soc 30: 115–128
Bernsmeier R, Bruhn HD, Pohl J (1981) Gerinnungsfaktoren (Thrombin, Faktor XIII, Kallikrein und Fibronectin) als Regulatoren der Proliferation von Fibroblasten, glatten Muskelzellen und Endothelzellen. Verh Dtsch Ges Inn Med 87: 782–785
Bruhn HD, Christophers E, Pohl J (1980) Gerinnungsfaktoren ( Thrombin, Faktor XIII) als Wachstumsfaktoren der Fibroblasten. Verh Dtsch Ges Inn Med 86: 1120–1123
Bruhn HD, Bernsmeier R, Broers H, Pohl J (1981) Regulation der Fibroblasten-und Endothelzellenproliferation durch Thrombin, Faktor XIII und Fibronectin. In: Blümel G, Haas S (Hrsg) Mikrozirkulation und Prostaglandinstoffwechsel. Schattauer, Stuttgart New York, S 257–265
Cunningham DD (1981) Proteases as growth factors. In: Baserga R (ed) Tissue growth factors. Springer, Berlin Heidelberg New York, pp 228–248
Laki K (1976) Faktor XIII und Metastasierung. In: Gastpar H (Hrsg) Onkohämostaseologie. Schattauer, Stuttgart New York, S 61–71
Maxfield FR, Davies PJA, Klempner L, Willingham MC, Pastan I (1979) Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits. Proc Natl Acad Sci USA 76: 5731–5735
Pohl J, Bruhn HD, Christophers E (1979) Thrombin and fibrin-induced growth of fibroblasts: role in wound repair and thrombus organization. Klin Wochenschr 57: 273–277
Rouslahti E, Vaheri A (1974) Novel human serumprotein from fibroblast plasma membrane. Nature 248: 789–791
Yamada K, Yamada S, Pastan I (1976) Cell surface protein partially restores morphology, adhesiveness and contact inhibition of movement to transformed fibroblasts. Proc Natl Acad Sci USA 73: 1217–1221
Kirchhof BRJ, Vermeer C, Hemker HC (1978) The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator. Thromb Res 13: 219
Avvisati G, TenCate JW, van Wijk EM, Kahlé LH, Marian G (1980) Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant therapy. Br J Haematol 45: 343
Bertina RM, van der Marel-van Nieuwkoop W, Loeliger EA (1979) Spectrophotometric assay of prothrombin in plasma of patients using oral anticoagulants. Thromb Haemostas 42: 1296
Kirchhof BRJ, Muller AD, Vermeer C, Hemker HC (1979) Control of anticoagulant therapy with a chromogenic substrate. Haemostasis 8: 1
Lämmle B, Eichlisberger R, Hänni L, Bounameaux H, Marberg GA, Duckert F (1979) Kontrolle der Antikoagulation: Vergleich zwischen Quick-und kolorimetrischer Faktor-X-Bestimmung bei 107 Patienten. Schweiz Med Wochenschr 109: 1115
Erskine JG, Walker ID, Davidson JF (1980) Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X. J Clin Pathol 33: 445
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Reimers, HJ. et al. (1982). Hämostasiologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 88. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47093-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-47093-6_25
Publisher Name: J.F. Bergmann-Verlag, Munich
Print ISBN: 978-3-8070-0332-0
Online ISBN: 978-3-642-47093-6
eBook Packages: Springer Book Archive